Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Clicks: 415
ID: 112562
1993
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
72.8
/100
414 views
331 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Seventy-four acutely ill patients were treated with intravenous ciprofloxacin at dosages ranging between 200 mg every 12 h and 400 mg every 8 h. A population pharmacokinetic-pharmacodynamic analysis relating drug exposure (and other factors) to infectious outcome was performed. Plasma samples were o …
| Reference Key |
a1993antimicrobialpharmacodynamics
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Forrest A;Nix DE;Ballow CH;Goss TF;Birmingham MC;Schentag JJ;; |
| Journal | Antimicrobial agents and chemotherapy |
| Year | 1993 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
algorithms
adult
female
male
aged
middle aged
Drug Administration Schedule
Prospective Studies
80 and over
Clinical Trial
multivariate analysis
ciprofloxacin / therapeutic use
ciprofloxacin / pharmacology*
analysis of variance
ciprofloxacin / pharmacokinetics
probability
pmid:8517694
pmc187901
doi:10.1128/aac.37.5.1073
a forrest
d e nix
j j schentag
bacterial infections / drug therapy
critical illness
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.